aTyr Pharma ATYR Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | $0-100% | $190K— | $0— | $0— | ||
| $7.32M-32.8% | $10.89M-50.8% | $22.13M+43.9% | $15.38M+30.2% | $11.81M-3.4% | ||
| $4.12M+5.5% | $3.91M-18.7% | $4.81M-2.5% | $4.93M+24.5% | $3.96M+10.2% | ||
| $11.44M-22.7% | $14.8M-45.1% | $26.94M+32.6% | $20.31M+28.8% | $15.77M-0.3% | ||
| -$11.44M+22.7% | -$14.8M+44.7% | -$26.75M-31.7% | -$20.31M-28.8% | -$15.77M+0.3% | ||
| $644K-22.6% | $832K-16.7% | $999K+27.9% | $781K-12.4% | $892K+4.7% | ||
| -$10.79M+22.7% | -$13.96M+45.8% | -$25.74M-31.8% | -$19.53M-31.3% | -$14.88M+0.6% | ||
| -$0.11+21.4% | -$0.14+46.2% | -$0.26-18.2% | -$0.22-29.4% | -$0.170.0% | ||
| -$11.27M+22.9% | -$14.63M+45.0% | -$26.58M-31.9% | -$20.15M-29.1% | -$15.61M+0.2% | ||
| -$11.44M+22.7% | -$14.8M+44.7% | -$26.75M-31.7% | -$20.31M-28.8% | -$15.77M+0.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is aTyr Pharma's revenue?
- aTyr Pharma (ATYR) generated $190.0K in revenue over the trailing twelve months, down 19.1% year over year.
- Is aTyr Pharma profitable?
- aTyr Pharma is not currently profitable: it reported a net loss of $70.0M over the trailing twelve months, a -39009.5% net margin.
- What is aTyr Pharma's earnings per share?
- aTyr Pharma's diluted EPS over the trailing twelve months is $-0.73.
- Where does aTyr Pharma's income statement data come from?
- Every line is extracted from aTyr Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
